Trials / Completed
CompletedNCT01665287
Cerebral Oximetry in Newborns - Comparing INVOS 5100 and FORE-SIGHT Cerebral Oximeters
Cerebral Oximetry in Newborns - Comparing INVOS 5100 and FORE-SIGHT Cerebral Oximeters Absolute Values, Sensitivity for Low Oxygen Levels and Reproducibility..
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 2 Minutes
- Healthy volunteers
- Accepted
Summary
Regional tissue oxygenation (rStO2) can be monitored by near infrared spectroscopy. The commercial devices FORE-SIGHT (CASMED) and INVOS (COVIDIEN) will be used simultaneously to test for their relative sensitivity for low oxygen levels just after birth on term infants born by elective cesarean section. Reproducibility will be examined by replacements of the sensors six times the next day when the infant is stable and quiet. Neonatal sensors will be used.
Conditions
Timeline
- Start date
- 2012-08-01
- Completion
- 2012-11-01
- First posted
- 2012-08-15
- Last updated
- 2013-01-15
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01665287. Inclusion in this directory is not an endorsement.